(Total Views: 107)
Posted On: 01/29/2021 1:00:48 PM
Post# of 15407

$BIIB News Article - Biogen and Eisai Announce FDA's 3-Month Extension of Review Period for the Biologics License Application for Aducanumab https://marketwirenews.com/news-releases/biog...42648.html


My Twitter: WhyteStocks